Koyfin Home > Directory > Health Care > Amicus Therapeutics > EBITDA / Interest Expenses

Amicus Therapeutics EBITDA / Interest Expenses Chart (FOLD)

Amicus Therapeutics annual/quarterly EBITDA / Interest Expenses from 2009 to 2009. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Amicus Therapeutics EBITDA / Interest Expenses for the quarter ending December 12, 2009 was $285m
Other Ratios Metrics:
  • Amicus Therapeutics Total Debt / Capital for the quarter ending September 09, 2018 was $44m a 27.22% increase of 12m year over year
  • Amicus Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $39m a -4.44% decrease of -2m year over year
  • Amicus Therapeutics Total Debt / Equity for the quarter ending September 09, 2018 was $78m a 39.91% increase of 31m year over year
View Chart On Koyfin

Quarterly FOLD EBITDA / Interest Expenses Data

12/2009$285m